ADAPTIN BIO, INC.
APTN · OTCMCIK 1938571fmd_03XW5NM2NHG3BJ6H88RPED1FBHManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2022 to Jun 30, 2026, 16 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Research and development | – | 2 | 2 |
| Total operating expenses | – | 3 | 5 |
| Operating income | (0) | (3) | (5) |
| Interest expense | – | 0 | 0 |
| Other non-operating income (expense) | – | (1) | 0 |
| Income before taxes | – | (3) | (5) |
| Net income | (0) | (3) | (5) |